Category: Other Treatments
Let’s pretend that you are a prostate cancer patient whose doctor, a well-known robotic surgeon, recommends robotic-assisted radical prostatectomy (RRP). He makes some very persuasive points: Based on the Partin tables you have less than a 12% chance of biochemical recurrence (rising PSA) in three years after treatment. He’ll “get it all out” and you keep reading
In 1991, Operation Desert Storm brought the first large-scale use of missile-type bombs that carried precision guidance systems, or “smart” bombs. Since these munitions could hit targets with great accuracy, collateral damage to civilians and civilian structures was greatly reduced. Now there is a new approach using smart bomb principles to treating metastatic prostate cancer keep reading
Men with localized prostate cancer (PCa) are usually given three treatment choices: radical prostatectomy (RP), external beam radiation therapy (EBRT) or Active Surveillance (AS). Although patients are rarely told about minimal-to-noninvasive treatments that can be applied as focal therapy, it’s somewhat heartening that urologists and radiologists are increasingly supportive of AS for low-risk patients. This keep reading
Reviews and ratings are very important in today’s world. Look at the internet. Whether it’s Yelp, Amazon, Ebay, Angie’s List or hundreds more, the number of stars or thumbs up are not as influential as the qualitative comments left by consumers. In similar fashion, radical prostatectomy is still upheld as the “gold standard” (click for keep reading
Men need testosterone, but prostate cancer does not. While there is new evidence that use of testosterone replacement therapy does not lead to prostate cancer, once prostate cancer has occurred, it appears to be fueled by testosterone. This is particularly bad news if prostate cancer has penetrated the edges of the gland capsule and begun keep reading
In the urologic world, there is a longstanding bias that surgical removal of the prostate gland, or radical prostatectomy (RP), is the preferred treatment for prostate cancer (PCa). It is based in the outdated belief that all PCa is a) multifocal, and b) likely to spread beyond the gland if untreated. Thus, it seemed logical keep reading
It is universally understood that the radical prostatectomy (RP) patient who has immediate return to baseline erectile function is a very rare case. The need to wear a catheter for several days to 2 weeks is itself a deterrent to having an erection. Even men who undergo nerve sparing robot-assisted laparascopic RP can expect a keep reading
“The customer is always right” is a motto or slogan which exhorts service staff to give a high priority to customer satisfaction. It was popularised by pioneering and successful retailers such as Harry Gordon Selfridge, John Wanamaker and Marshall Field. (Wikipedia) “The customer is always right” is sometimes wrong, as many companies have learned when disgruntled keep reading
If you have prostate cancer (PCa) but you also have a coexisting condition like high blood pressure, cardiovascular disease or diabetes, are you a good candidate for a radical (meaning total gland) treatment? It could turn out to be a rougher journey than you bargained on. A January, 2017 publication reports on the relationship between keep reading
Prostate cancer is a slow-growing disease associated with aging, though younger men may develop more aggressive forms. Another process also associated with aging is dementia, which means declining mental and cognitive function. The incidence of both conditions begins to increase from age 65 onward. The most common treatment recommended for men with low-to-intermediate risk prostate keep reading
